Compounded GLP-1 Program

Safe. Monitored. Personalized.

Beginning October 2025, Precision Primary Care will begin a partnership with Empower Pharmacy to provide compounded GLP-1 weight loss medications for patients who are unable to obtain them through their insurance.

GLP-1 medications such as semaglutide (Ozempic/Wegovy) and tirzepatide (Zepbound/Mounjaro) are powerful tools for weight management, that best when combined with ongoing medical monitoring, lifestyle support, and a structured care plan.

The goal of this program is to increase access to these breakthrough medications, helping patients obtain treatment at the lowest possible cost—while still ensuring safety, close monitoring, and personalized care.

A Personal Message About GLP-1 Treatment

Dear Patients,

I want to share something very personal with you, because I believe access to this medication can truly change lives. I know this from experience — it has changed mine.

In my own medical journey, there have been two major interventions that transformed my health:

1. Treating my mild sleep apnea with a CPAP machine, which improved my energy and mood.

2. Starting GLP-1 therapy (semaglutide), which completely changed my relationship with food and hunger.

For the first time in 37 years, I feel like I am in control of my eating. Over the past two years, while taking compounded semaglutide through various compounding pharmacies, I’ve lost 57 pounds. On average, I was paying $300–$400 per month out of pocket. To me, there’s a world of difference between paying $350 and paying $200, and I know lowering the cost of this medication can open access for many patients who have shared the same struggles.

Cameron Campbell, CRNP
Precision Primary Care | Precision Mental Health

  • Another reason I feel strongly about offering this program is safety. In a perfect world, all patients who pay insurance premiums every month would have this medication covered so it could change their lives, just as it has changed mine. Unfortunately, that’s not the reality.

    It is frustrating as a provider to prescribe medications for blood pressure, cholesterol, diabetes, or sleep apnea, and to see infertility in PCOS patients — all conditions that are often consequences of obesity — yet not be able to treat the root cause itself. Too often, we are left prescribing “Band-Aid” medications for problems that stem from obesity, rather than addressing the obesity itself.

    The final straw for me in setting up this program and partnering with Empower Pharmacy was, again, safety. These are real medications that require real prescriptions and real monitoring. In my 11 years of practice, I’ve had to stop GLP-1 therapy in some patients for safety reasons, just as with any medication. It made me very uncomfortable to hear patients were receiving GLP-1 prescriptions from their dentist, their psychiatrist, or even through signs posted in a mental health office waiting room.

    I take immense pride in practicing medicine a certain way: spending more time with patients, listening, monitoring, and making decisions carefully. We sometimes sacrifice profit at our practice because I refuse to rush visits. To me, patient safety always comes first. And if my patients are taking GLP-1 medications, I want to be the one guiding, monitoring, and protecting them — not someone who may lack experience with these powerful medications.

    I never wanted to be in a position of running a program like this. But I believe insurance coverage is only getting worse, not better. I’ve seen fewer approvals in 2025 than in 2024, and trends suggest coverage will continue to decline over the next 1–2 years. Retail prices remain $500+ per month, even with manufacturer programs, and that simply isn’t sustainable for most people.

    This program is designed to bring the cost closer to $200 a month — while ensuring patients get appropriate monitoring, guidance, and safety oversight from me directly. I feel strongly that if I do not step in, my patients will continue to be placed at risk by providers or services more focused on profit than patient well-being.

    I would never want a patient to put something in their body that I would not put in mine. That is why I believe in this program, why I use these medications myself, and why I want to offer them to you in the safest and most affordable way possible.

Insurance, Monitoring Program & Costs

Semaglutide:

  • Expected Weight Loss (12–18 mo): ~15–17% of baseline bodyweight (many reach ≥10–20% loss)

  • Average Cost Per Month (Medication + Monitoring Program): $162–$225

  • Additional Benefits: FDA-approved reduction in heart attack, stroke, and cardiovascular death in overweight/obese adults

Tirzepatide:

  • Expected Weight Loss (12–18 mo): ~20–26% of baseline bodyweight (many reach ≥25% loss)

  • Average Cost Per Month (Medication + Monitoring Program): $238–$431

  • Additional Benefits: Reduced risk of cardiovascular death or worsening heart failure in patients with HFpEF + obesity

Insurance & Monitoring Program:

Monitoring Program: $50 first month, then $150/month (required for Empower prescriptions)

The practice will still continue to try and get all patients interested in starting a GLP-1 Medication their medication through insurance. Patients getting their medication covered through insurance through the retail pharmacy do not need to be subscribed to the GLP-1 Monitoring program. This program is primarily for patients who are unable to get the medication through their insurance.

What’s Included in the Monitoring Program:

  • Biweekly weight check-ins via portal

  • Medication management and dose titration

  • Administration teaching at the practice as well as the option of having the medication administered by Precision Staff weekly if desired.

  • Side effect monitoring and support

  • Direct pharmacy coordination (refills, communication, Shipping assurance and troubleshooting)

  • Medication discounts through negotiated pricing

  • Safer care — prescribed and monitored by your PCP, not a third-party telehealth company

How They Work

GLP-1 medications like semaglutide work in two main ways:

  1. Reducing hunger signaling (satiety center of the brain): These medications quiet hunger signals, so food choices become less about cravings and more about fueling your body.

  2. Delaying gastric emptying: Food stays in your stomach longer, which makes you feel full more quickly and for longer.

These two mechanisms together mean most people naturally eat half to two-thirds as much food as before — without forcing dietary changes or extra exercise. The result: sustainable, consistent weight loss.